SCHEDULED CARDIAC SURGERY WITH EXTRACORPOREAL CIRCULATION

Clinical trials for SCHEDULED CARDIAC SURGERY WITH EXTRACORPOREAL CIRCULATION explained in plain language.

Never miss a new study

Get alerted when new SCHEDULED CARDIAC SURGERY WITH EXTRACORPOREAL CIRCULATION trials appear

Sign up with your email to follow new studies for SCHEDULED CARDIAC SURGERY WITH EXTRACORPOREAL CIRCULATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Heart surgery drug trial aims to stop kidney failure

Disease control Ongoing

This study is testing whether using the drug vasopressin to maintain blood pressure after heart surgery is better at preventing kidney failure or death than the standard drug, noradrenaline. It involves 840 adults at high risk for kidney problems who are having planned heart surg…

Matched conditions: SCHEDULED CARDIAC SURGERY WITH EXTRACORPOREAL CIRCULATION

Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

SCHEDULED CARDIAC SURGERY WITH EXTRACORPOREAL CIRCULATION

Get alerted when new SCHEDULED CARDIAC SURGERY WITH EXTRACORPOREAL CIRCULATION trials appear

Heart surgery drug trial aims to stop kidney failure